Comments
Loading...

Organon

OGNNYSE
Logo brought to you by Benzinga Data
$18.78
0.854.74%
At close: -
$18.79
0.01000.05%
After Hours: 5:01 PM EDT
15 minutes delayed
Q3 2024 earnings were released today before the market open
Today's conference call ended over 15 hours ago Click to view past webcast
Dermavant was acquired by Organon (OGN) on Monday, October 28, 2024 for $1.2B

Organon (NYSE:OGN) Stock, Short Interest Report

Short interest in Organon & Co (NYSE:OGN) increased during the last reporting period, rising from 9.77M to 12.53M. This put 6.51% of the company's publicly available shares short.

Short interest for Organon gives investors a sense of the degree to which investors are betting on the decline of Organon's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.09M shares traded per day, it would take 5.98 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.

Short Interest
12.53M
Short Interest %
6.51%
Days to Cover
5.98
Data brought to you by Benzinga APIs

Looking for the most shorted stocks?

People Also Watch